Insider sale
CORBUS PHARMACEUTICALS HOLDINGS, INC.
$121.0K
12K shares
What this filing means
STIFEL, NICOLAUS & COMPANY, INC CIAS /FA plans to sell 12K shares of CORBUS PHARMACEUTICALS HOLDINGS, INC. valued at approximately $121.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/7/2026ACC: 0001972481-26-000255
→
12K
Shares to sell
$121.0K
Approx. market value
12K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Units
Equity Compensation
2/12/2026
7.32KRestricted Stock Units
Equity Compensation
1/31/2026
4.68KTotal acquired12K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/12/2026 | Restricted Stock Units Equity Compensation | 7.32K | — |
1/31/2026 | Restricted Stock Units Equity Compensation | 4.68K | — |
| Total | 12K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
12K
Market value
$121.0K
8/7/2026
Total
Units
12K
Value
$121.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/7/2026 | 12K | $121.0K | Nasdaq | Planned |
| Total | 12K | $121.0K | ||